Literature DB >> 2919520

First description of "Indian childhood cirrhosis" in a non-Indian infant in Europe.

M Weiss1, J Müller-Höcker, B Wiebecke, B H Belohradsky.   

Abstract

The first female child of healthy German parents, breast-fed for 5 weeks, developed progressive abdominal distension due to hepatosplenomegaly at the age of 7 months and died from acute liver failure 3 months later. Histology showed destruction of liver architecture with extreme hepatocellular copper storage, characteristic of "Indian childhood cirrhosis" (ICC). The family received drinking water from a well via copper pipes. The copper level of the water was extremely elevated (430 and 5510 micrograms/l) so that exogenous copper intake during the first months of life may have induced the fatal liver disease, probably in association with an unproven genetic disposition. This is the first description of a case of ICC in a member of a non-Indian family in Europe.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2919520     DOI: 10.1111/j.1651-2227.1989.tb10908.x

Source DB:  PubMed          Journal:  Acta Paediatr Scand        ISSN: 0001-656X


  4 in total

1.  Changing pattern of chronic liver disease (CLD) in India.

Authors:  S Bhave; A Bavdekar; A Pandit
Journal:  Indian J Pediatr       Date:  1994 Nov-Dec       Impact factor: 1.967

2.  Long term survival in Indian childhood cirrhosis treated with D-penicillamine.

Authors:  A R Bavdekar; S A Bhave; A M Pradhan; A N Pandit; M S Tanner
Journal:  Arch Dis Child       Date:  1996-01       Impact factor: 3.791

3.  Fulminant hepatic failure resulting from coexistent Wilson's disease and hepatitis E.

Authors:  R Sallie; J Chiyende; K C Tan; D Bradley; B Portmann; R Williams; A P Mowat; G Mieli-Vergani
Journal:  Gut       Date:  1994-06       Impact factor: 23.059

4.  Acute gastrointestinal effects of graded levels of copper in drinking water.

Authors:  F Pizarro; M Olivares; R Uauy; P Contreras; A Rebelo; V Gidi
Journal:  Environ Health Perspect       Date:  1999-02       Impact factor: 9.031

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.